Pulmonary arterial hypertension (PAH) is a vasoconstrictive disease of the distal pulmonary
vasculature resulting in adverse right heart remodeling. Pregnancy in PAH patients is …

The United States has a long history of undermining the reproductive autonomy of people
with chronic conditions. This includes people with disabilities that are seen or unseen, and …

Background: The US Food and Drug Administration approved phentermine–topiramate for
obesity in 2012 and required a Risk Evaluation and Mitigation Strategy (REMS) to prevent …

Objectives To describe female adolescents' reproductive health needs and subspecialists'
teratogenic counseling at initiation of mycophenolate as well as use of reproductive health …

This article discusses the Supreme Court's ruling in Dobbs v. Jackson and the concerns it
raises for patients with rheumatic disease and their clinicians, including access to medically …

Abstract Introduction The US FDA required a Risk Evaluation and Mitigation Strategy
(REMS) for phentermine/topiramate, an anti-obesity medication, to prevent congenital …

Importance Teratogenic outcomes associated with valproic acid use represent a substantial
concern for persons of childbearing age. Regulatory agencies worldwide have enhanced …

BACKGROUND Risk mitigation for most teratogenic medications relies on risk
communication via drug label, and prenatal exposures remain common. Information on the …

Statins, widely prescribed for cholesterol management by inhibiting HMG-CoA reductase in
the cholesterol biosynthesis pathway, may also influence vertebrate development. In this …

Knight and colleagues must be commended for their cross-sectional study from the UK
Epilepsy and Pregnancy Register evidencing that children exposed to topiramate in utero …